BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24434439)

  • 1. Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+ T lymphocytes of patients with unstable angina undergoing percutaneous coronary intervention.
    Su Q; Li L; Liu Y; Zhou Y; Wang J; Sun Y
    Cardiology; 2014; 127(3):169-75. PubMed ID: 24434439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury.
    Yu XL; Zhang HJ; Ren SD; Geng J; Wu TT; Chen WQ; Ji XP; Zhong L; Ge ZM
    Coron Artery Dis; 2011 Mar; 22(1):87-91. PubMed ID: 21169815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period.
    Ye H; He F; Fei X; Lou Y; Wang S; Yang R; Hu Y; Chen X
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):290-5. PubMed ID: 24346155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
    Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
    Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.
    Li Q; Deng SB; Xia S; Du JL; She Q
    Med Clin (Barc); 2013 Jun; 140(12):532-6. PubMed ID: 23177313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovičová L; Tomašov P; Tesař D
    Am J Cardiol; 2011 May; 107(9):1295-9. PubMed ID: 21349484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Sun F; Yin Z; Shi Q; Zhao B; Wang S
    Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.
    Briguori C; Visconti G; Focaccio A; Golia B; Chieffo A; Castelli A; Mussardo M; Montorfano M; Ricciardelli B; Colombo A
    J Am Coll Cardiol; 2009 Dec; 54(23):2157-63. PubMed ID: 19664895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Atorvastatin Therapy Attenuates the Inflammatory Responses in Monocytes of Patients with Unstable Angina Undergoing Percutaneous Coronary Intervention via Peroxisome Proliferator-Activated Receptor γ Activation.
    Yang J; Liu C; Zhang L; Liu Y; Guo A; Shi H; Liu X; Cheng Y
    Inflammation; 2015 Aug; 38(4):1415-23. PubMed ID: 25604313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study): rationale and design.
    Liu P; Jiang J; Li J; Hong T; Zhang Y; Yu R; Jia J; Huo Y
    Catheter Cardiovasc Interv; 2012 May; 79(6):967-71. PubMed ID: 22514150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
    Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
    Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
    Toso A; Leoncini M; Maioli M; Gallopin M; Tedeschi D; Amato M; Bellandi F
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):318-21. PubMed ID: 21045713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.